N-[4-[(2-amino-4-pyridinyl)oxy]-3-fluorophenyl]-6-ethyl-1,2-dimethyl-4-oxoquinoline-3-carboxamide
C25H23FN4O3 — CID 126617918
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[(2-amino-4-pyridinyl)oxy]-3-fluorophenyl]-6-ethyl-1,2-dimethyl-4-oxoquinoline-3-carboxamide
N-[4-[(2-amino-4-pyridinyl)oxy]-3-fluorophenyl]-6-ethyl-1,2-dimethyl-4-oxoquinoline-3-carboxamide (PubChem CID 126617918) has the molecular formula C25H23FN4O3 and a molecular weight of 446.48 g/mol. Its IUPAC name is N-[4-[(2-amino-4-pyridinyl)oxy]-3-fluorophenyl]-6-ethyl-1,2-dimethyl-4-oxoquinoline-3-carboxamide.
Molecular Properties
| Compound Name | N-[4-[(2-amino-4-pyridinyl)oxy]-3-fluorophenyl]-6-ethyl-1,2-dimethyl-4-oxoquinoline-3-carboxamide |
|---|---|
| PubChem CID | 126617918 |
| Molecular Formula | C25H23FN4O3 |
| Molecular Weight | 446.48 g/mol |
| Exact Mass | 446.18 |
| IUPAC Name | N-[4-[(2-amino-4-pyridinyl)oxy]-3-fluorophenyl]-6-ethyl-1,2-dimethyl-4-oxoquinoline-3-carboxamide |
| SMILES | CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ccnc(N)c3)c(F)c1)c(C)n2C |
| InChI | InChI=1S/C25H23FN4O3/c1-4-15-5-7-20-18(11-15)24(31)23(14(2)30(20)3)25(32)29-16-6-8-21(19(26)12-16)33-17-9-10-28-22(27)13-17/h5-13H,4H2,1-3H3,(H2,27,28)(H,29,32) |
| InChIKey | LLIOGMJHPWCYCR-UHFFFAOYSA-N |
| XLogP | 4.57 |
| TPSA | 99.24 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 446.48 |
| LogP ≤ 5 | 4.57 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126617918 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.